Company: NCEL
Filing Date: 2025-10-17
Form Type: POS AM
Source: 0001213900-25-099986
Chunk: 72

Company: NewcelX Ltd.
Filing Date: 2025-10-17
Form: POS AM
Chunk 72
---
 would waive any and all liquidated damages arising from such claims. This make whole provision settled on June 27, 2025 with the issuance of 485,000pre -fundedcommon share warrants with an exercise price equal to par value and Alpha agreed that the issuance fully satisfied any and all claims. Given the nominal exercise price the fair value of the pre -fundedwarrants was based on the market price of the Company’s common shares on the settlement date of $ 2.54. The Company recognized a deemed dividend of $ 1,231,900for the aggregate value of the pre -fundedwarrants. During the six months ended June 30, 2025, the Company has reflected a total of $ 1,845,839in deemed dividends for the above transactions which has been presented within shareholders’ equity and increases the net loss available to common shareholders in the computation of loss per share on the statements of operations. Annex A-17 NLS PHARMACEUTICS LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

Warrants During the six months ended June 30, 2025, the Company had the following common share warrant issuances: • 1,181,818warrants with an exercise price of $ 1.80per share exercisable for five years in the March 2025 SPA • 192,308pre -fundedwarrants as a commitment fee pursuant to an equity line of credit executed with Alpha • 485,000pre -fundedwarrants pursuant to a make whole provision in the March 2025 SPA

The following table summarizes the common share warrant activity for the six-month period ended June 30, 2025:

|                                                      |     |    Shares |   |     | Weighted 
 Average  
 Exercise 
 Price    |       |     |    Weighted 
     Average 
 Contractual 
        Term |
|:-----------------------------------------------------|:----|----------:|:--|:----|:---------|------:|:----|------------:|
| Balance at January 1, 2025                           |     | 1,598,962 |   |     | $        | 16.44 |     |        3.32 |
| Issuances                                            |     | 1,859,126 |   |     |          |  1.16 |     |             |
| Exercises                                            |     |   (76,817 | ) |     |